Bibliographic Details
| Title: |
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) |
| Authors: |
Gaillard, Stephanie, Oaknin, Ana, Ray-Coquard, Isabelle, Vergote, Ignace, Scambia, Giovanni, Colombo, Nicoletta, Fernandez, Cristian, Alfaro, Vicente, Kahatt, Carmen, Nieto, Antonio, Zeaiter, Ali, Aracil, Miguel, Vidal, Laura, Pardo-Burdalo, Beatriz, Papai, Zsuzsanna, Kristeleit, Rebecca, O'Malley, David M., Benjamin, Ivor, Pautier, Patricia, Lorusso, Domenica |
| Source: |
In Gynecologic Oncology November 2021 163(2):237-245 |
| Database: |
ScienceDirect |
